Growth Differentiation Factor 11 Regulates High Glucose-induced Cardiomyocyte Pyroptosis and Diabetic Cardiomyopathy by Inhibiting Inflammasome Activation

Overview

Journal Cardiovasc Diabetol

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
Endocrinology

Date 2024 May 7

PMID 38715043

Authors

Jing Zhang

Guolong Wang

Yuxuan Shi

Xin Liu

Shuang Liu

Wendi Chen

Yunna Ning

Yongzhi Cao

Yueran Zhao

Ming Li

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic cardiomyopathy (DCM) is a crucial complication of long-term chronic diabetes that can lead to myocardial hypertrophy, myocardial fibrosis, and heart failure. There is increasing evidence that DCM is associated with pyroptosis, a form of inflammation-related programmed cell death. Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor β superfamily, which regulates oxidative stress, inflammation, and cell survival to mitigate myocardial hypertrophy, myocardial infarction, and vascular injury. However, the role of GDF11 in regulating pyroptosis in DCM remains to be elucidated. This research aims to investigate the role of GDF11 in regulating pyroptosis in DCM and the related mechanism.

Methods And Results: Mice were injected with streptozotocin (STZ) to induce a diabetes model. H9c2 cardiomyocytes were cultured in high glucose (50 mM) to establish an in vitro model of diabetes. C57BL/6J mice were preinjected with adeno-associated virus 9 (AAV9) intravenously via the tail vein to specifically overexpress myocardial GDF11. GDF11 attenuated pyroptosis in H9c2 cardiomyocytes after high-glucose treatment. In diabetic mice, GDF11 alleviated cardiomyocyte pyroptosis, reduced myocardial fibrosis, and improved cardiac function. Mechanistically, GDF11 inhibited pyroptosis by preventing inflammasome activation. GDF11 achieved this by specifically binding to apoptosis-associated speck-like protein containing a CARD (ASC) and preventing the assembly and activation of the inflammasome. Additionally, the expression of GDF11 during pyroptosis was regulated by peroxisome proliferator-activated receptor α (PPARα).

Conclusion: These findings demonstrate that GDF11 can treat diabetic cardiomyopathy by alleviating pyroptosis and reveal the role of the PPARα-GDF11-ASC pathway in DCM, providing ideas for new strategies for cardioprotection.

Citing Articles

Cardioprotective Effects of Dapagliflozin and Trimetazidine on Doxorubicin-Induced Cardiotoxicity in Streptozotocin-Induced Type 1 Diabetic Rats via Endoplasmic Reticulum Stress.

Ogutveren M, Satiroglu O, Ozden Z, Akyildiz K, Yilmaz A, Mercantepe F J Clin Med. 2025; 14(4).

PMID: 40004844 PMC: 11856595. DOI: 10.3390/jcm14041315.

Regulation of transcription factor function by purinergic signalling in cardiovascular diseases.

Tang H, Kong Q, Zhang Z, Wu W, Yuan L, Liu X Purinergic Signal. 2024; .

PMID: 39215950 DOI: 10.1007/s11302-024-10045-8.

References

Schafer M, Atkinson E, Vanderboom P, Kotajarvi B, White T, Moore M . Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. Cell Metab. 2016; 23(6):1207-1215. PMC: 4913514. DOI: 10.1016/j.cmet.2016.05.023. View

Ritchie R, Abel E . Basic Mechanisms of Diabetic Heart Disease. Circ Res. 2020; 126(11):1501-1525. PMC: 7251974. DOI: 10.1161/CIRCRESAHA.120.315913. View

Loffredo F, Steinhauser M, Jay S, Gannon J, Pancoast J, Yalamanchi P . Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153(4):828-39. PMC: 3677132. DOI: 10.1016/j.cell.2013.04.015. View

Kar S, Shahshahan H, Hackfort B, Yadav S, Yadav R, Kambis T . Exercise Training Promotes Cardiac Hydrogen Sulfide Biosynthesis and Mitigates Pyroptosis to Prevent High-Fat Diet-Induced Diabetic Cardiomyopathy. Antioxidants (Basel). 2019; 8(12). PMC: 6943713. DOI: 10.3390/antiox8120638. View

Asbun J, Villarreal F . The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol. 2006; 47(4):693-700. DOI: 10.1016/j.jacc.2005.09.050. View

Dillmann W . Diabetic Cardiomyopathy. Circ Res. 2019; 124(8):1160-1162. PMC: 6578576. DOI: 10.1161/CIRCRESAHA.118.314665. View

Wang L, Wang Y, Wang Z, Qi Y, Zong B, Liu M . Growth differentiation factor 11 ameliorates experimental colitis by inhibiting NLRP3 inflammasome activation. Am J Physiol Gastrointest Liver Physiol. 2018; 315(6):G909-G920. DOI: 10.1152/ajpgi.00159.2018. View

Zhu H, Zhang L, Zhai M, Xia L, Cao Y, Xu L . GDF11 Alleviates Pathological Myocardial Remodeling in Diabetic Cardiomyopathy Through SIRT1-Dependent Regulation of Oxidative Stress and Apoptosis. Front Cell Dev Biol. 2021; 9:686848. PMC: 8273395. DOI: 10.3389/fcell.2021.686848. View

Wu L, Wang K, Wang W, Wen Z, Wang P, Liu L . Glucagon-like peptide-1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway. Aging Cell. 2018; 17(4):e12763. PMC: 6052396. DOI: 10.1111/acel.12763. View

10.

Du G, Shao Z, Wu J, Yin W, Li S, Wu J . Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury. Basic Res Cardiol. 2016; 112(1):7. DOI: 10.1007/s00395-016-0593-y. View

11.

Satoh T, Kambe N, Matsue H . NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation. Cell Death Dis. 2013; 4:e644. PMC: 3674376. DOI: 10.1038/cddis.2013.169. View

12.

Karki R, Kanneganti T . Diverging inflammasome signals in tumorigenesis and potential targeting. Nat Rev Cancer. 2019; 19(4):197-214. PMC: 6953422. DOI: 10.1038/s41568-019-0123-y. View

13.

Fu J, Wu H . Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation. Annu Rev Immunol. 2023; 41:301-316. PMC: 10159982. DOI: 10.1146/annurev-immunol-081022-021207. View

14.

Finck B, Lehman J, Leone T, Welch M, Bennett M, Kovacs A . The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002; 109(1):121-30. PMC: 150824. DOI: 10.1172/JCI14080. View

15.

Zhaolin Z, Guohua L, Shiyuan W, Zuo W . Role of pyroptosis in cardiovascular disease. Cell Prolif. 2018; 52(2):e12563. PMC: 6496801. DOI: 10.1111/cpr.12563. View

16.

Zhang J, Li Y, Li H, Zhu B, Wang L, Guo B . GDF11 Improves Angiogenic Function of EPCs in Diabetic Limb Ischemia. Diabetes. 2018; 67(10):2084-2095. DOI: 10.2337/db17-1583. View

17.

Li Z, Xu H, Liu X, Hong Y, Lou H, Liu H . GDF11 inhibits cardiomyocyte pyroptosis and exerts cardioprotection in acute myocardial infarction mice by upregulation of transcription factor HOXA3. Cell Death Dis. 2020; 11(10):917. PMC: 7585938. DOI: 10.1038/s41419-020-03120-6. View

18.

Broz P, Pelegrin P, Shao F . The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2019; 20(3):143-157. DOI: 10.1038/s41577-019-0228-2. View

19.

Gilbert R, Krum H . Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy. Lancet. 2015; 385(9982):2107-17. DOI: 10.1016/S0140-6736(14)61402-1. View

20.

Wang L, Cai Y, Jian L, Cheung C, Zhang L, Xia Z . Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy. Cardiovasc Diabetol. 2021; 20(1):2. PMC: 7783984. DOI: 10.1186/s12933-020-01188-0. View